Evaluation of Disinfection Therapy for Atopic Dermatitis
International Journal of Clinical & Experimental Dermatology · 2016
DOI: 10.33140/ijced.01.01.06 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Clinical & Experimental Dermatology, 2016. Die Arbeit nennt 76 Literaturangaben.
Abstract (Originalsprache)
There is a susceptibility to infection in one of the pathogenesis of atopic dermatitis [1-4]. Kobayashi et al. Have reported that Staphylococcus aureus in the onset and exacerbation of atopic dermatitis is involved [5]. From more of the skin of moderate or atopic dermatitis Staphylococcus aureus has been detected 100%. Staphylococcus aureus produce toxins at a high frequency. The toxins produced by Staphylococcus aureus will act as a super antigen [6]. That is, unlike the produce toxin normal antigens, by acting on antigen-presenting cells, and induce the order of magnitude of cytokines. In atopic dermatitis, as a failure of organs other than the skin, there are reports that acknowledge the lesions of the intestinal tract and cervical spine [7,8].
Zitieren
APA
(2016). Evaluation of Disinfection Therapy for Atopic Dermatitis. International Journal of Clinical & Experimental Dermatology. https://doi.org/10.33140/ijced.01.01.06
Vancouver
Evaluation of Disinfection Therapy for Atopic Dermatitis. International Journal of Clinical & Experimental Dermatology. 2016. doi:10.33140/ijced.01.01.06
BibTeX
@article{euvimed2016,
title = {Evaluation of Disinfection Therapy for Atopic Dermatitis},
journal = {International Journal of Clinical & Experimental Dermatology},
year = {2016},
doi = {10.33140/ijced.01.01.06}
}
EUVIMED